Drug Shortage Report for PAL-TIZANIDINE
Report ID | 4361 |
Drug Identification Number | 02239170 |
Brand name | PAL-TIZANIDINE |
Common or Proper name | ZANAFLEX |
Company Name | PALADIN LABS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TIZANIDINE |
Strength(s) | 4MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 150 TABS |
ATC code | M03BX |
ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2012-10-03 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-03-27 | French | Compare |
v1 | 2017-03-27 | English | Compare |
Showing 1 to 2 of 2